Cargando…
An AP Perspective on Infusion Reactions in the Era of Immunotherapy
As cancer care advances, creative uses for immunotherapy continue to be developed, but it is also important to be cognizant of the risk for infusion reactions. At JADPRO Live Virtual 2021, Carrie Peterson, DNP, RN, AGNP-c, reviewed the different classes and pathophysiology of immunotherapy, how to a...
Autor principal: | Peterson, Carrie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126347/ https://www.ncbi.nlm.nih.gov/pubmed/35663179 http://dx.doi.org/10.6004/jadpro.2022.13.3.13 |
Ejemplares similares
-
Allergic/infusion reactions reported with cetuximab and rituximab
por: Wolf, Ray A, et al.
Publicado: (2015) -
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, December 5(th) 2015
por: Ascierto, Paolo A., et al.
Publicado: (2016) -
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016
por: Ascierto, Paolo A., et al.
Publicado: (2017) -
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
por: Ascierto, Paolo A., et al.
Publicado: (2022) -
Highlights of Miami winter symposium 2015: into the era of immunotherapy
por: Zhou, Wen
Publicado: (2015)